太龙药业：2025年第三次临时股东大会决议公告

Core Viewpoint - Tai Long Pharmaceutical announced the approval of multiple proposals, including the cancellation of the supervisory board and amendments to related articles, during its third extraordinary general meeting of shareholders for 2025 [2] Group 1 - The company held its third extraordinary general meeting of shareholders on August 15 [2] - The meeting resulted in the approval of the proposal to cancel the supervisory board [2] - Amendments to related articles were also approved during the meeting [2]